A Pilot Randomized Controlled Trial of the Feasibility, Acceptability, and Impact of Giving Information on Personalized Genomic Risk of Melanoma to the Public
Amelia K Smit, David Espinoza, Ainsley J Newson, Rachael L Morton, Georgina Fenton, Lucinda Freeman, Kate Dunlop, Phyllis N Butow, Matthew H Law, Michael G Kimlin, Louise A Keogh, Suzanne J Dobbinson, Judy Kirk, Peter A Kanetsky, Graham J Mann, Anne E Cust
Cancer Epidemiology Biomarkers & Prevention | AMER ASSOC CANCER RESEARCH | Published : 2017
Awarded by National Health and Medical Research Council of Australia (NHMRC)
Awarded by Cancer Institute NSW
Awarded by NHMRC Sidney Sax Fellowship
This study received funding from Sydney Catalyst Translational Cancer Research Centre and The University of Sydney Cancer Strategic Priority Area for Research Collaboration (SPARC) Implementation Scheme. A.E. Cust received Career Development Fellowships from the National Health and Medical Research Council of Australia (NHMRC; 1063593) and Cancer Institute NSW (15/CDF/1-14). R.L. Morton was supported by a NHMRC Sidney Sax Fellowship (1054216). M.G. Kimlin is supported through a Cancer Council Queensland Professorial Chair in Cancer Prevention.